Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples